---
schema_version: "secwatch.filing_event.v1"
accession: "0001854270-24-000036"
form_type: "8-K"
ticker: "SNTI"
cik: "0001854270"
company_name: "Senti Biosciences, Inc."
filed_at: "2024-04-26T23:59:59+00:00"
generated_at: "2026-06-03T06:42:32.103519+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Senti Bio CFO Deborah Knobelman resigns; search for interim CFO underway

## Summary
- Deborah Knobelman, Ph.D., CFO, Treasurer and Head of Corp. Dev., resigned effective May 3, 2024.
- Resignation not due to any disagreement with the company on operations, policies, or practices.
- Company entered consulting agreement with Knobelman effective May 4, 2024, for transition; max payment $60,000.
- Company has initiated search to identify an interim CFO and treasurer.

## SEC filing metadata
- accession: 0001854270-24-000036
- form_type: 8-K
- ticker: SNTI
- cik: 0001854270
- company_name: Senti Biosciences, Inc.
- filed_at: 2024-04-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1854270/000185427024000036/0001854270-24-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1854270/000185427024000036/snti-20240423.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001854270-24-000036
- JSON: https://secwatch.observer/filing/0001854270-24-000036.json
- Plain text: https://secwatch.observer/filing/0001854270-24-000036.txt

## Key facts
- Executive change
  Deborah Knobelman resigned as Chief Financial Officer, Treasurer and Head of Corporate Development at Senti Biosciences, Inc..
  - Action: resigned
  - Role: Chief Financial Officer, Treasurer and Head of Corporate Development
  source text: On April 23, 2024, Deborah Knobelman, Ph.D., the Chief Financial Officer, Treasurer and Head of Corporate Development of Senti Biosciences Inc. (“the Company”) and its principal financial officer and principal accounting officer, notified the Company of her decision to resign from her employment with the Company, effective May 3, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1854270/000185427024000036/0001854270-24-000036-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.